Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics"" wg kryterium: PB

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 992
Tytuł:
Human organ chips for regenerative pharmacology.
Autorzy:
Goyal G; Wyss Institute for Biologically, Inspired Engineering at Harvard University, Boston, Massachusetts, USA.
Belgur C; Wyss Institute for Biologically, Inspired Engineering at Harvard University, Boston, Massachusetts, USA.
Ingber DE; Wyss Institute for Biologically, Inspired Engineering at Harvard University, Boston, Massachusetts, USA.; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e01159.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Microphysiological Systems*
Lab-On-A-Chip Devices*
Animals ; Humans ; Models, Animal ; Drug Discovery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical considerations on monkeypox antiviral medications: An overview.
Autorzy:
Pourkarim F; Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Entezari-Maleki T; Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.; Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e01164.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Mpox (monkeypox)*/drug therapy
Humans ; Antiviral Agents/adverse effects ; Cidofovir ; Benzamides ; Isoindoles
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A descriptive pharmacokinetic/pharmacodynamic analysis of ceftazidime-avibactam in a case series of critically ill patients with augmented renal clearance.
Autorzy:
Xu Y; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Tang J; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Yuan B; Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
Luo X; Department of Pharmacy, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
Liang P; Department of Pharmacy, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
Liu N; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Dong D; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Jin L; Department of Pharmacy, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
Ge W; Department of Pharmacy, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
Gu Q; Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e01163.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Critical Illness*/therapy
Humans ; Ceftazidime/pharmacology ; Ceftazidime/therapeutic use ; Azabicyclo Compounds/pharmacology ; Azabicyclo Compounds/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The blockade of the TGF-β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesity.
Autorzy:
Xu WD; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China.
Lai SZ; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China.
Zhao J; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China.
Wei SJ; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China.
Fang XY; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China.
Liu YY; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China.
Rong XL; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China.
Guo J; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China.; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1160.
Typ publikacji:
Journal Article
MeSH Terms:
Lipid Metabolism*
Lipodystrophy*/drug therapy
Mice ; Animals ; Transforming Growth Factor beta/metabolism ; Sterol Regulatory Element Binding Protein 1/metabolism ; Glycerol ; Obesity/drug therapy ; Obesity/metabolism ; Glucose/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safety.
Autorzy:
Jiang C; Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.; Hangzhou Medical College, Hangzhou, Zhejiang, China.
Qian J; Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.
Jiang X; Wenling Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Wenling, Zhejiang, China.
Zhang S; Hangzhou Medical College, Hangzhou, Zhejiang, China.
Zheng J; Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.
Wang H; Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.; Hangzhou Medical College, Hangzhou, Zhejiang, China.; Department of Anesthesiology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1161.
Typ publikacji:
Journal Article
MeSH Terms:
Pharmacovigilance*
Narcolepsy*/drug therapy
Humans ; Retrospective Studies ; Piperidines/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Antioxidant potential of chlorogenic acid in Age-Related eye diseases.
Autorzy:
Tang Y; Department of Ophthalmology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.; Hunan University of Chinese Medicine, Changsha, China.
Fang C; Department of Scientific Research, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
Shi J; Hunan University of Chinese Medicine, Changsha, China.; Hunan Provincial Key Laboratory for Prevention and Treatment of Ophthalmology and Otolaryngology Diseases with Chinese Medicine, Changsha, China.
Chen H; Hunan University of Chinese Medicine, Changsha, China.; Hunan Provincial Key Laboratory for Prevention and Treatment of Ophthalmology and Otolaryngology Diseases with Chinese Medicine, Changsha, China.
Chen X; Department of Ophthalmology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.; Hunan University of Chinese Medicine, Changsha, China.
Yao X; Department of Ophthalmology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.; Hunan University of Chinese Medicine, Changsha, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1162.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Eye Diseases*/drug therapy
Diabetic Retinopathy*/drug therapy
Humans ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Chlorogenic Acid/pharmacology ; Chlorogenic Acid/therapeutic use ; Oxidative Stress
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A systematic review on experimental studies about patient adherence to treatment.
Autorzy:
Folkvord F; PredictBy, Barcelona, Spain.; Tilburg Center for Cognition and Communication (TiCC), Department of Communication and Cognition, Tilburg University, Tilburg, The Netherlands.
Würth AR; PredictBy, Barcelona, Spain.
van Houten K; PredictBy, Barcelona, Spain.
Liefveld AR; Link2Trials, Hilversum, The Netherlands.
Carlson JI; PredictBy, Barcelona, Spain.
Bol N; Tilburg Center for Cognition and Communication (TiCC), Department of Communication and Cognition, Tilburg University, Tilburg, The Netherlands.
Krahmer E; Tilburg Center for Cognition and Communication (TiCC), Department of Communication and Cognition, Tilburg University, Tilburg, The Netherlands.
Beets G; Tilburg Center for Cognition and Communication (TiCC), Department of Communication and Cognition, Tilburg University, Tilburg, The Netherlands.
Ollerton RD; Tilburg Center for Cognition and Communication (TiCC), Department of Communication and Cognition, Tilburg University, Tilburg, The Netherlands.
Turk E; Institute for Health and Society, University of Oslo, Oslo, Norway.
Hrubos-Strøm H; Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Nahoui H; Akershus University Hospital, Lørenskog, Norway.
Einvik G; Akershus University Hospital, Lørenskog, Norway.
Schirmer H; Akershus University Hospital, Lørenskog, Norway.
Moen A; Institute for Health and Society, University of Oslo, Oslo, Norway.
Barrio-Cortes J; Foundation for Biosanitary Research and Innovation in Primary Care, Madrid, Spain.; Research Unit, Primary Healthcare Management, Madrid Health Service, Madrid, Spain.; University Camilo José Cela, Madrid, Spain.
Merino-Barbancho B; Universidad Politécnica de Madrid, Life Supporting Technologies Research Group, Madrid, Spain.
Arroyo P; Universidad Politécnica de Madrid, Life Supporting Technologies Research Group, Madrid, Spain.
Fico G; Universidad Politécnica de Madrid, Life Supporting Technologies Research Group, Madrid, Spain.
Midão L; Associate Laboratory i4HB - Institute for Health and Bioeconomy, UCIBIO - Applied Molecular Biosciences Unit, Porto4Ageing - Competence Centre on Active and Healthy Ageing, Faculty of Pharmacy of the University of Porto, Porto, Portugal.
Sampaio R; , Department of Biomedicine, Faculty of Medicine of the University of Porto, Porto, Portugal.
Fonseca JA; MEDIDA, Medicina, EDucação, I&D e Avaliação Lda, Portugal.; MEDCIDS, Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
Geipel K; Department of Otorhinolaryngology, Heinrich-Heine-University, Düsseldorf, Germany.
Scheckenbach K; Department of Otorhinolaryngology, Heinrich-Heine-University, Düsseldorf, Germany.
de Ruiter LE; Behavioral Science Consortium, Astellas Pharma, Northbrook, Illinois, USA.
Lupiáñez-Villanueva F; PredictBy, Barcelona, Spain.; Universidad Oberta de Catalunya, Information and Communication Sciences, Barcelona, Spain.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1166.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Health Care Costs*
Patient Compliance*
Humans ; Databases, Factual ; World Health Organization
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-world treatment outcomes of immune checkpoint inhibitors used off-label in oncology: A comprehensive cancer institution experience.
Autorzy:
Fontanals S; Pharmacy Department, Catalan Institute of Oncology (ICO)- Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Medicine, Universitat de Barcelona (UB), ICO, Hospitalet de Llobregat, Barcelona, Spain.
Esteve A; Research Management Unit (UGR), Catalan Institute of Oncology (ICO), Medical Oncology Department, ICO-Badalona, Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
González A; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
Ibáñez C; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Blanquerna Ramon Llull University, School of Health Sciences, ICO, Hospitalet de Llobregat, Barcelona, Spain.
Mesía R; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
Clopés A; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Health Sciences, Blanquerna Ramon Llull University, ICO, Hospitalet de Llobregat, Barcelona, Spain.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1167.
Typ publikacji:
Journal Article
MeSH Terms:
Immune Checkpoint Inhibitors*/therapeutic use
Neoplasms*/drug therapy
Male ; Humans ; Female ; Middle Aged ; Off-Label Use ; Medical Oncology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 protein.
Autorzy:
Wu Y; Department of Periodontics, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China.; Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou, China.; Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, China.
Gong P; Department of Stomatology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1169.
Typ publikacji:
Journal Article
MeSH Terms:
Periodontal Ligament*
Core Binding Factor Alpha 1 Subunit*/genetics
Humans ; Osteogenesis ; Stem Cells ; Scopolamine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of a pharmaceutical science systematic review process using a semi-automated machine learning tool: Intravenous drug compatibility in the neonatal intensive care setting.
Autorzy:
De Silva DTN; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
Moore BR; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.; Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia, Australia.; Medical School, The University of Western Australia, Crawley, Western Australia, Australia.; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia.
Strunk T; Medical School, The University of Western Australia, Crawley, Western Australia, Australia.; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia.; Neonatal Directorate, King Edward Memorial Hospital, Child and Adolescent Health Service, Subiaco, Western Australia, Australia.
Petrovski M; Pharmacy Department, King Edward Memorial Hospital, Women and Newborn Health Service, Subiaco, Western Australia, Australia.
Varis V; University Library, Curtin University, Perth, Western Australia, Australia.
Chai K; School of Population Health, Curtin University, Perth, Western Australia, Australia.
Ng L; Curtin School of Allied Health, Curtin University, Perth, Western Australia, Australia.; School of Health Sciences, Swinburne University of Technology, Hawthorn, Victoria, Australia.
Batty KT; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.; Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia, Australia.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1170.
Typ publikacji:
Journal Article
MeSH Terms:
Intensive Care, Neonatal*
Machine Learning*
Systematic Reviews as Topic*
Humans ; Infant, Newborn ; Reproducibility of Results
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Epigenetics in obesity: Mechanisms and advances in therapies based on natural products.
Autorzy:
Chen P; Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
Wang Y; Department of Pharmacy, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, Hubei, P.R. China.
Chen F; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, P.R. China.
Zhou B; Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1171.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Anti-Obesity Agents*/pharmacology
Anti-Obesity Agents*/therapeutic use
Neoplasms*
Humans ; Obesity/drug therapy ; Obesity/genetics ; Obesity/metabolism ; Epigenesis, Genetic ; Polyphenols/pharmacology ; Polyphenols/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The impact of phosphodiesterase-5 inhibition or angiotensin-converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload.
Autorzy:
Tykvartova T; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.; Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Miklovic M; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.; Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Kotrc M; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
Skaroupkova P; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
Kazdova L; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
Trnovska J; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
Skop V; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.; Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Czech Republic.
Kolar M; Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
Novotny J; Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
Melenovsky V; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1172.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin-Converting Enzyme Inhibitors*/pharmacology
Heart Failure*/drug therapy
Ventricular Remodeling*
Phosphodiesterase 5 Inhibitors*/pharmacology
Animals ; Male ; Rats ; Cardiomegaly/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
2-Deoxyglucose and hydroxychloroquine HPLC-MS-MS analytical methods and pharmacokinetic interactions after oral co-administration in male rats.
Autorzy:
Sun D; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.; Pennsylvania State University College of Medicine Mass Spectrometry Core Facility, Hershey, Pennsylvania, USA.
Kim S; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Karelia D; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Deng Y; Department of Urology, University of Minnesota College of Medicine, Minneapolis, Minnesota, USA.
Jiang C; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Lü J; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.; Penn State Cancer Institute, Hershey, Pennsylvania, USA.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1173.
Typ publikacji:
Journal Article
MeSH Terms:
Hydroxychloroquine*/pharmacokinetics
Liquid Chromatography-Mass Spectrometry*
Male ; Rats ; Animals ; Chromatography, High Pressure Liquid ; Administration, Oral ; Deoxyglucose
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients.
Autorzy:
Ikenaka K; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Kajiyama Y; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Aguirre C; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Choong CJ; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Taniguchi S; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Doi J; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Wang N; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Ajiki T; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Ogawa K; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Kakuda K; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Kimura Y; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Mochizuki H; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1174.
Typ publikacji:
Journal Article
MeSH Terms:
Parkinson Disease*/drug therapy
Humans ; Levodopa/therapeutic use ; Levodopa/adverse effects ; Antiparkinson Agents/pharmacology ; Antiparkinson Agents/therapeutic use ; Vitamin B 6/therapeutic use ; Albumins/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inhibition of PDE-4 isoenzyme attenuates frequency and overall contractility of agonist-evoked ureteral phasic contractions.
Autorzy:
Lim I; Centre for Urology, Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia.
Masutani T; Department of Cell Physiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Hashitani H; Department of Cell Physiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Chess-Williams R; Centre for Urology, Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia.
Sellers D; Department of Cell Physiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1175.
Typ publikacji:
Journal Article
MeSH Terms:
Phosphodiesterase 4 Inhibitors*/pharmacology
Ureter*/physiology
Animals ; Swine ; Rolipram/pharmacology ; Cyclic Nucleotide Phosphodiesterases, Type 4 ; Isoenzymes ; Phosphodiesterase 5 Inhibitors/pharmacology ; Serotonin/pharmacology ; Tadalafil
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of G protein-coupled receptor kinases (GRKs) in β 2 -adrenoceptor-mediated glucose uptake.
Autorzy:
Ham S; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Mukaida S; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Sato M; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Keov P; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Bengtsson T; Atrogi AB, Stockholm, Sweden.; Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Furness S; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Holliday ND; School of Life Sciences, The Medical School, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Excellerate Bioscience, Biocity, Nottingham, UK.
Evans BA; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Summers RJ; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Hutchinson DS; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1176.
Typ publikacji:
Journal Article
MeSH Terms:
G-Protein-Coupled Receptor Kinases*
Glucose*/metabolism
Rats ; Animals ; Isoproterenol/pharmacology ; Receptors, G-Protein-Coupled ; Receptors, Adrenergic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacology education in the medical curriculum: Challenges and opportunities for improvement.
Autorzy:
Fasinu PS; Department of Pharmacology & Toxicology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Wilborn TW; Department of Pharmacology & Toxicology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1178.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Curriculum*
Education, Medical, Undergraduate*
Humans ; Problem-Based Learning ; Drug Delivery Systems
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Validity, sensitivity and specificity of a measure of medication adherence instrument among patients taking oral anticoagulants.
Autorzy:
Marques MD; School of Nursing, University of Campinas, São Paulo, Brazil.
Pedrosa RBDS; School of Nursing, University of Campinas, São Paulo, Brazil.
Oliveira HC; School of Nursing, University of Campinas, São Paulo, Brazil.
Gallani MCBJ; Sciences infirmières, Université Laval, Quebec City, Quebec, Canada.
Rodrigues RCM; School of Nursing, University of Campinas, São Paulo, Brazil.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Dec; Vol. 11 (6), pp. e01113.
Typ publikacji:
Journal Article
MeSH Terms:
Anticoagulants*/therapeutic use
Medication Adherence*
Humans ; Psychometrics ; Reproducibility of Results ; Brazil
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The role of plasma concentrations and drug characteristics of beta-blockers in fall risk of older persons.
Autorzy:
Ploegmakers KJ; Amsterdam UMC Location University of Amsterdam, Internal Medicine, Section of Geriatric Medicine, Amsterdam, The Netherlands.; Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands.
van Poelgeest EP; Amsterdam UMC Location University of Amsterdam, Internal Medicine, Section of Geriatric Medicine, Amsterdam, The Netherlands.; Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands.
Seppala LJ; Amsterdam UMC Location University of Amsterdam, Internal Medicine, Section of Geriatric Medicine, Amsterdam, The Netherlands.; Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands.
van Dijk SC; Department of Geriatrics, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
de Groot LCPGM; Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.
Oliai Araghi S; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Schoor NM; Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands.; Amsterdam UMC Location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, Netherlands.
Stricker B; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Swart KMA; Amsterdam UMC Location Vrije Universiteit Amsterdam General Practice, Amsterdam, The Netherlands.
Uitterlinden AG; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Mathôt RAA; Amsterdam UMC Location University of Amsterdam, Hospital Pharmacy-Clinical Pharmacology, Amsterdam, The Netherlands.
van der Velde N; Amsterdam UMC Location University of Amsterdam, Internal Medicine, Section of Geriatric Medicine, Amsterdam, The Netherlands.; Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Dec; Vol. 11 (6), pp. e01126.
Typ publikacji:
Journal Article
MeSH Terms:
Metoprolol*/adverse effects
Adrenergic beta-Antagonists*/adverse effects
Humans ; Aged ; Aged, 80 and over ; Carvedilol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab.
Autorzy:
Miguel-Lillo B; Medical Department, mAbxience Research S.L., Madrid, Spain.
Sánchez-Vidaurre S; Medical Department, mAbxience Research S.L., Madrid, Spain.
Pérez Díaz L; Medical Department, mAbxience Research S.L., Madrid, Spain.
Paravisini A; Medical Department, mAbxience Research S.L., Madrid, Spain.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Dec; Vol. 11 (6), pp. e01139.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Biosimilar Pharmaceuticals*/adverse effects
Biosimilar Pharmaceuticals*/pharmacokinetics
Humans ; Antibodies, Monoclonal ; Area Under Curve ; Bevacizumab/adverse effects ; Bevacizumab/pharmacokinetics ; Therapeutic Equivalency
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 992

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies